Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study-Reference-Cited by-同舟云学术

Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study

Published:2020-05-28 Issue:7 Volume:79 Page:986.2-988
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Salvarani Carlo^ORCID,Bajocchi Gianluigi,Mancuso Pamela,Galli Elena,Muratore Francesco,Boiardi Luigi,Catanoso Mariagrazia,Pipitone Nicolò,Cassone Giulia,Girolimetto Nicolò,Croci Stefania,Cimino Luca,Gradellini Federeica,Beltrami Marina,Di Lernia Vito,Dolci Giovammi,Massari Marco,Marata Anna Maria,Costantini Massimo,Giorgi Rossi Paolo

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference4 articles.

1. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis;Singh;The Lancet,2015

2. Viral infections in the biologic therapy era;Noreña;Expert Rev Anti Infect Ther,2018

3. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

4. D’Antiga L . Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transpl 2020.doi:10.1002/lt.25756

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2;Viruses;2023-06-27

2. The impact of the COVID-19 pandemic on SLE;Modern Rheumatology;2023-03-24

3. Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response;Frontiers in Immunology;2023-03-09

4. DMARD TREATMENT AND COVID-19 PREVALENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS;ACTA MEDICA MEDITERR;2023

5. COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data;Advances in Rheumatology;2022-11-22